Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTEMV5X)

DTT Name Serine protease unspecific (SP)
Gene Name SP
DTT Type
Successful target
 [1]
UniProt ID
NOUNIPROTAC
TTD ID
T20297

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
4 Approved Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aprotinin DM0QD4W Bleeding disorder GA20-GA21 Approved [1]
Gabexate DMU9D2F Pancreatitis DC31-DC34 Approved [2]
Nafamostat DMU1XOD Pancreatitis DC31-DC34 Approved [2]
Sivelestat sodium hydrate DMOSJD0 Acute lung injury NB32.3 Phase 4 [3]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Camostat DMQ7UL8 Cystic fibrosis CA25 Phase 2 [4]
VT-111a DMY9ZGN Acute coronary syndrome BA41 Phase 2 [5]
------------------------------------------------------------------------------------
3 Discontinued Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sepimostat mesylate DMRBYH8 Solid tumour/cancer 2A00-2F9Z Discontinued in Phase 3 [6]
NPI-1999 DMH1YL8 Thrombosis DB61-GB90 Terminated [8]
SDZ-MTH-958 DMKCXBJ Artery stenosis BD52 Terminated [9]
------------------------------------------------------------------------------------
1 Preclinical Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
VT-111 DMOY15R Graft rejection in heart transplantation NE84 Preclinical [7]
------------------------------------------------------------------------------------

References

1 Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding Clin Trials. 2005;2(3):218-29; discussion 229-32.
2 Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients. Int J Oncol. 2009 Jul;35(1):115-20.
3 Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2006 May;11(2):275-91.
4 Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension. J Hypertens. 2009 Jan;27(1):181-9.
5 Viral Serpin Therapeutics: From Concept to Clinic. Methods Enzymol. 2011; 499: 301-329.
6 Effect of FUT-187, oral serine protease inhibitor, on inflammation in the gastric remnant. Gan To Kagaku Ryoho. 1996 Dec;23(14):1971-9.
7 New developments in immunosuppressive therapy for heart transplantation. Expert Opin Emerg Drugs. 2009 Mar;14(1):1-21.
8 US patent application no. 2005,0096,323, Diketopiperazine derivatives to inhibit thrombin.
9 Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection. Transplantation. 1996 Mar 27;61(6):862-8.